Historical record - last NADAC effective date: 2/11/2015

Product Information

RETIN-A MICRO 0.1% GEL is a brand product labeled by Bausch Health US LLC, priced at $17.7570 per GM under NDC 00187514020. Its NADAC has been published 23 times since Feb 11, 2015.

FDA first approved this application on Feb 7, 1997. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

RETIN-A MICRO 0.1% GEL

Tretinoin
$17.7570per GM

Strength

1 mg/g

NDC

00187514020

Classification

Brand

Dosage Form

GEL

Route

TOPICAL

Effective Date

2/11/2015

Active Ingredients

TRETINOIN

Approval Type

New Drug (NDA)

FDA Application

NDA020475

FDA Approved

2/7/1997

TE Code

AB

On Market Since

2/7/1997

Pharmacological Classes

Retinoid
Retinoids

Price Statistics

The NADAC for RETIN-A MICRO 0.1% GEL has been published 23 times since Feb 11, 2015, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$17.7570 per GM
All-time high$17.7570 (Jul 15, 2015)
All-time low$17.7570 (Feb 11, 2015)
Median price$17.7570
Average price$17.7570
Largest weekly change0.0% (Feb 18, 2015)
Weeks tracked23
Tracking sinceFeb 11, 2015

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

N/A

3Y

N/A

5Y

N/A

All

0.0%

Last surveyed Jul 15, 2015 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 58% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 58%

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of RETIN-A MICRO 0.1% GEL?

The current National Average Drug Acquisition Cost (NADAC) for RETIN-A MICRO 0.1% GEL, manufactured by Bausch Health US LLC, is $17.7570 per GM (NDC 00187514020), effective Jul 15, 2015.

How has the price of RETIN-A MICRO 0.1% GEL changed over time?

Over the history we have for it, the NADAC for RETIN-A MICRO 0.1% GEL has held within roughly two percent of its current level. It has been tracked across 23 weekly CMS publications since Feb 11, 2015.

What are the highest and lowest recorded NADAC prices for RETIN-A MICRO 0.1% GEL?

Since Feb 11, 2015, the NADAC for RETIN-A MICRO 0.1% GEL has ranged from a low of $17.7570 (Feb 11, 2015) to a high of $17.7570 (Jul 15, 2015), with a median of $17.7570 per GM.

Are there cheaper alternatives to RETIN-A MICRO 0.1% GEL?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TRETINOIN GEL MICRO 0.1% TUBE, is $7.4226 per GM — about 58% below RETIN-A MICRO 0.1% GEL.

Who manufactures RETIN-A MICRO 0.1% GEL?

RETIN-A MICRO 0.1% GEL (NDC 00187514020) is labeled by Bausch Health US LLC, and CMS classifies it as a brand product.